Refining risk stratification for locoregional failure after chemoradiotherapy in human papillomavirus-associated oropharyngeal cancer

Oral Oncology

Volumn 50, Issue 5, 2014, Pages 513-519

  Vainshtein, Jeffrey M ^a   Spector, Matthew E ^b   McHugh, Jonathan B ^b   Wong, Ka Kit ^b   Walline, Heather M ^a   Byrd, Serena A ^b   Komarck, Christine M ^a   Ibrahim, Mohannad ^a   Stenmark, Matthew H ^a   Prince, Mark E ^b   Bradford, Carol R ^b   Wolf, Gregory T ^b   McLean, Scott ^b   Worden, Francis P ^b   Chepeha, Douglas B ^b   Carey, Thomas ^b   Eisbruch, Avraham ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

EGFR; FDG PET; HPV; Local regional failure; Oropharyngeal cancer; Risk stratification

Indexed keywords

CARBOPLATIN; CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUORODEOXYGLUCOSE; PACLITAXEL; PROTEIN P16;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CHEMORADIOTHERAPY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GENE OVEREXPRESSION; HUMAN; INDUCTION CHEMOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; NECK DISSECTION; OROPHARYNX CANCER; PAPILLOMAVIRUS INFECTION; PATIENT; PATIENT SELECTION; PREDICTIVE VALUE; PREDICTOR VARIABLE; PRIMARY TUMOR; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; THORAX RADIOGRAPHY; TREATMENT FAILURE; ISOLATION AND PURIFICATION; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OROPHARYNGEAL NEOPLASMS; PAPILLOMA VIRUS; TREATMENT OUTCOME; VIROLOGY;

ADULT; AGED; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 84899105566     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2014.02.001     Document Type: Article

References (28)

1. K.K. Ang, J. Harris, R. Wheeler, R. Weber, D.I. Rosenthal, and P.F. Nguyen-Tan et al. Human papillomavirus and survival of patients with oropharyngeal cancer N Engl J Med 363 2010 24 35
2. H. Quon, and A.A. Forastiere Controversies in treatment deintensification of human papillomavirus-associated oropharyngeal carcinomas: should we, how should we, and for whom? J Clin Oncol 31 2013 520 522
3. S.C. Patel, T. Hackman, D.N. Hayes, and B.S. Chera De-intensification of treatment for human papilloma virus associated oropharyngeal squamous cell carcinoma: a discussion of current approaches Pract Radiat Oncol 2 2012 282 287
4. B. O'Sullivan, S.H. Huang, B. Perez-Ordonez, C. Massey, L.L. Siu, and I. Weinreb et al. Outcomes of HPV-related oropharyngeal cancer patients treated by radiotherapy alone using altered fractionation Radiother Oncol 103 2012 49 56
5. B. O'Sullivan, S.H. Huang, L.L. Siu, J. Waldron, H. Zhao, and B. Perez-Ordonez et al. Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis J Clin Oncol 31 2013 543 550
6. M.L. Gillison, Q. Zhang, R. Jordan, W. Xiao, W.H. Westra, and A. Trotti et al. Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer J Clin Oncol 30 2012 2102 2111
7. G.W. Warren, S.M. Arnold, J.P. Valentino, T.J. Gal, A.J. Hyland, and A.K. Singh et al. Accuracy of self-reported tobacco assessments in a head and neck cancer treatment population Radiother Oncol 103 2012 45 48
8. K.S. Chao, G. Ozyigit, A.I. Blanco, W.L. Thorstad, J.O. Deasy, and B.H. Haughey et al. Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume Int J Radiat Oncol Biol Phys 59 2004 43 50
9. D.L. Schwartz, J. Rajendran, B. Yueh, M.D. Coltrera, M. Leblanc, and J. Eary et al. FDG-PET prediction of head and neck squamous cell cancer outcomes Arch Otolaryngol Head Neck Surg 130 2004 1361 1367
10. A. Hong, T. Dobbins, C.S. Lee, D. Jones, E. Jackson, and J. Clark et al. Relationships between epidermal growth factor receptor expression and human papillomavirus status as markers of prognosis in oropharyngeal cancer Eur J Cancer 46 2010 2088 2096
11. K.K. Ang, B.A. Berkey, X. Tu, H.Z. Zhang, R. Katz, and E.H. Hammond et al. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma Cancer Res 62 2002 7350 7356
12. B.H. Lok, J. Setton, N. Caria, J. Romanyshyn, S.L. Wolden, and M.J. Zelefsky et al. Intensity-modulated radiation therapy in oropharyngeal carcinoma: effect of tumor volume on clinical outcomes Int J Radiat Oncol Biol Phys 82 2012 1851 1857
13. B. Kumar, K.G. Cordell, J.S. Lee, F.P. Worden, M.E. Prince, and H.H. Tran et al. EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer J Clin Oncol 26 2008 3128 3137
14. C. Tang, J.D. Murphy, B. Khong, T.H. La, C. Kong, and N.J. Fischbein et al. Validation that metabolic tumor volume predicts outcome in head-and-neck cancer Int J Radiat Oncol Biol Phys 83 2012 1514 1520
15. A.L. Tang, S.J. Hauff, J.H. Owen, M.P. Graham, M.J. Czerwinski, and J.J. Park et al. UM-SCC-104: a new human papillomavirus-16-positive cancer stem cell-containing head and neck squamous cell carcinoma cell line Head Neck 34 2012 1480 1491
16. M.E. Spector, K.K. Gallagher, E. Light, M. Ibrahim, E.J. Chanowski, and J.S. Moyer et al. Matted nodes: poor prognostic marker in oropharyngeal squamous cell carcinoma independent of HPV and EGFR status Head Neck 34 2012 1727 1733
17. H.M. Walline, C. Komarck, J.B. McHugh, S.A. Byrd, M.E. Spector, and S.J. Hauff et al. High-risk human papillomavirus detection in oropharyngeal, nasopharyngeal, and oral cavity cancers: comparison of multiple methods JAMA Otolaryngol Head Neck Surg 139 2013 1320 1327
18. A. Eisbruch, L.H. Marsh, L.A. Dawson, C.R. Bradford, T.N. Teknos, and D.B. Chepeha et al. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing Int J Radiat Oncol Biol Phys 59 2004 28 42
19. N. Reimers, H.U. Kasper, S.J. Weissenborn, H. Stutzer, S.F. Preuss, and T.K. Hoffmann et al. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer Int J Cancer 120 2007 1731 1738
20. R.J. Young, D. Rischin, R. Fisher, G.A. McArthur, S.B. Fox, and L.J. Peters et al. Relationship between epidermal growth factor receptor status, p16(INK4A), and outcome in head and neck squamous cell carcinoma Cancer Epidemiol Biomarkers Prev 20 2011 1230 1237
21. C.S. Kong, B. Narasimhan, H. Cao, S. Kwok, J.P. Erickson, and A. Koong et al. The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas Int J Radiat Oncol Biol Phys 74 2009 553 561
22. M. Machtay, M. Natwa, J. Andrel, T. Hyslop, P.R. Anne, and J. Lavarino et al. Pretreatment FDG-PET standardized uptake value as a prognostic factor for outcome in head and neck cancer Head Neck 31 2009 195 201
23. P. Xie, M. Li, H. Zhao, X. Sun, Z. Fu, and J. Yu 18F-FDG PET or PET-CT to evaluate prognosis for head and neck cancer: a meta-analysis J Cancer Res Clin Oncol 137 2011 1085 1093
24. Y.H. Joo, I.R. Yoo, K.J. Cho, J.O. Park, I.C. Nam, and M.S. Kim Preoperative F-FDG PET/CT and high-risk HPV in patients with oropharyngeal squamous cell carcinoma Head Neck 2013
25. K.A. Higgins, J.K. Hoang, M.C. Roach, J. Chino, D.S. Yoo, and T.G. Turkington et al. Analysis of pretreatment FDG-PET SUV parameters in head-and-neck cancer: tumor SUVmean has superior prognostic value Int J Radiat Oncol Biol Phys 82 2012 548 553
26. A. Eisbruch, H.M. Kim, F.Y. Feng, T.H. Lyden, M.J. Haxer, and M. Feng et al. Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: swallowing organs late complication probabilities and dosimetric correlates Int J Radiat Oncol Biol Phys 81 2011 e93 e99
27. A. Eisbruch, R.K. Ten Haken, H.M. Kim, L.H. Marsh, and J.A. Ship Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer Int J Radiat Oncol Biol Phys 45 1999 577 587
28. A.S. Garden, L. Dong, W.H. Morrison, E.M. Stugis, B.S. Glisson, and S.J. Frank et al. Patterns of disease recurrence following treatment of oropharyngeal cancer with intensity modulated radiation therapy Int J Radiat Oncol Biol Phys 2012